
|Videos|April 21, 2022
Patient Quality of Life on Lenvatinib plus Pembrolizumab Treatment for Renal Cell Carcinoma
Oncologists review quality of life data for patients with renal cell carcinoma receiving lenvatinib plus pembrolizumab combination treatments.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Brexucabtagene Autoleucel in Adult R/R MCL
2
CAR-T Moves to the Front Line: Rethinking the Multiple Myeloma Sequence
3
Urine-Based Biopsy Shows 97.8% Sensitivity in Prostate Cancer Detection
4
EMERALD-3 Durvalumab Combo Improves PFS in Embolization-Eligible HCC
5

































































